エクソソーム診断・治療の市場規模：由来別、技術別、エンドユーザー別、地域別、範囲および予測

エクソソーム診断・治療市場規模と予測

世界のエクソソーム診断・治療市場規模は、2023年に4億9,000万米ドルと評価され、2024年から2031年にかけて29.62%のCAGRで成長し、2031年には30億1,000万米ドルに達すると予測されています。エクソソーム診断と治療には、小さな細胞外小胞（エクソソーム）を使用して病気を診断・治療することが含まれます。エクソソームは早期発見のためのバイオマーカーを持ち、標的細胞に治療用化学物質を直接投与することができます。エクソソーム診断学は、生理学的体液中のバイオマーカーを評価することにより、特にがんにおいて、病気の早期発見を可能にします。エクソソームはオーダーメイドの治療を行い、ドラッグデリバリーの効率を高め、副作用を低減し、組織再生や免疫学的調節のための再生医療への応用を改善します。

エクソソーム診断と治療は、特にがん、神経疾患、再生医療において、病気の早期発見、標的薬剤の投与、個別化治療、治療効果の非侵襲的モニタリングに役立つ可能性があります。これらは患者の転帰を改善し、革新的なヘルスケアソリューションを提供します。

世界のエクソソーム診断・治療市場力学

主な市場促進要因

エクソソーム研究の進歩：

エクソソームの生物学的性質や細胞間情報伝達における役割が解明されるにつれ、バイオマーカーや治療薬としての可能性への関心が高まっています。分離および特性解析技術の進歩により、診断および治療におけるエクソソームの有用性が高まっています。

慢性疾患の有病率の増加：

がん、心血管疾患、神経変性疾患などの慢性疾患の有病率が拡大しているため、新たな診断・治療アプローチの必要性が高まっています。エクソソームは早期発見と集中治療のための有望な道筋を提示し、市場の成長をもたらします。

個別化医療への投資：

エクソソーム市場は、特定の患者プロファイルに基づく個別化治療に焦点が移行するにつれて成長しています。エクソソームに基づく診断と治療は個別化医療技術を補完し、正確で患者に特化した回答をもたらします。

主要課題：

エクソソーム研究の進歩：

エクソソームの生物学と細胞間情報伝達における役割が解明されるにつれ、バイオマーカーや治療薬としての可能性への関心が高まっています。分離および特性解析技術の進歩により、診断および治療におけるエクソソームの有用性が高まっています。

慢性疾患の有病率の増加：

がん、心血管疾患、神経変性疾患などの慢性疾患の有病率が拡大しているため、新たな診断・治療アプローチの必要性が高まっています。エクソソームは早期発見と集中治療のための有望な道筋を提示し、市場の成長をもたらします。

個別化医療への投資：

エクソソーム市場は、特定の患者プロファイルに基づく個別化治療に焦点が移行するにつれて成長しています。エクソソームに基づく診断と治療は個別化医療技術を補完し、正確で患者固有の答えを与えます。

主要動向：

投資と研究資金の増加：

エクソソームをベースとした診断と治療の研究は、かなりの投資と資金増加が見られます。政府、研究機関、営利企業は、疾患の早期発見とオーダーメイド治療におけるエクソソームの価値をますます認識するようになっており、その結果、資金が増加しています。

エクソソーム単離精製技術の進歩

エクソソーム単離精製技術の技術開発により、業界は前進しています。超遠心分離、マイクロ流体工学、免疫捕捉アプローチなどの改良された技術は、エクソソーム抽出の効率と収量を増加させ、信頼できる診断および治療アプリケーションの開発を容易にします。

腫瘍学における用途の拡大：

がんの診断と治療におけるエクソソームの使用は、増加傾向にあります。エクソソームは細胞間コミュニケーションにおいて重要な機能を果たし、多くのがんのバイオマーカーを輸送することができます。エクソソームは、抗がん剤を腫瘍細胞に直接送達し、副作用を最小限に抑え、治療効果を向上させる可能性が検討されています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 エクソソーム診断・治療市場：由来別

• 自己由来エクソソーム
• 同種エクソソーム

第5章 エクソソーム診断・治療市場：技術別

• 電子顕微鏡
• フローサイトメトリー
• 質量分析
• ナノ粒子追跡分析（NTA）

第6章 エクソソーム診断・治療市場：エンドユーザー別

• 病院・クリニック
• 研究・学術機関
• バイオテクノロジーおよび製薬会社

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Thermo Fisher Scientific Inc
• Lonza Group AG
• Bio-Techne Corp
• Miltenyi Biotec GmBH
• Malvern Instruments Inc
• BioVision Inc
• System Biosciences LLC
• Evox Therapeutics Ltd
• ExCoBio Inc
• BioCat GmbH
• NanoSomix Inc
• Exosome Diagnostics Inc

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Exosome Diagnostic And Therapeutic Market Size And Forecast

Global Exosome Diagnostic and Therapeutic Market size was valued at USD 490 Million in 2023 and is projected to reach USD 3010 Million by 2031, growing at a CAGR of 29.62% from 2024 to 2031. Exosome diagnostics and treatments involve the use of small extracellular vesicles, or exosomes to diagnose and treat diseases. They carry biomarkers for early detection and can administer therapeutic chemicals directly to target cells, which improves precision medicine and reduces adverse effects. Exosome diagnostics allows for early illness identification, particularly in cancer, by evaluating biomarkers in physiological fluids. Exosomes administer tailored treatments, increasing drug delivery efficiency, lowering adverse effects and improving regenerative medicine applications for tissue regeneration and immunological regulation.

Exosome diagnostics and therapies have the potential to aid in early illness identification, targeted drug administration, personalized therapy and non-invasive monitoring of treatment efficacy, particularly in cancer, neurological diseases and regenerative medicine. They offer to improve patient outcomes and provide innovative healthcare solutions.

Global Exosome Diagnostic and Therapeutic Market Dynamics

The key market dynamics that are shaping the global exosome diagnostic and therapeutic market include:

Key Market Drivers:

Exosome Research Advancements:

As we learn more about exosome biology and their role in intercellular communication, we are becoming increasingly interested in their potential as biomarkers and therapeutics. Advances in separation and characterization techniques are increasing the utility of exosomes in diagnostics and therapy.

Growing Prevalence of Chronic Diseases:

The expanding prevalence of chronic diseases, such as cancer, cardiovascular disease and neurodegenerative disorders, increases the need for novel diagnostic and therapeutic approaches. Exosomes present a prospective path for early detection and focused treatment, resulting in market growth.

Investment in Personalized Medicine:

The exosome market is growing as the focus shifts to individualized treatments based on specific patient profiles. Exosome-based diagnostics and therapies complement personalized medicine techniques, giving precise and patient-specific answers.

Key Challenge:

Exosome Research Advancements:

As we learn more about exosome biology and their role in intercellular communication, we are becoming increasingly interested in their potential as biomarkers and therapeutics. Advances in separation and characterization techniques are increasing the utility of exosomes in diagnostics and therapy.

Growing Prevalence of Chronic Diseases:

The expanding prevalence of chronic diseases, such as cancer, cardiovascular disease and neurodegenerative disorders, increases the need for novel diagnostic and therapeutic approaches. Exosomes present a prospective path for early detection and focused treatment, resulting in market growth.

Investment in Personalized Medicine:

The exosome market is growing as the focus shifts to individualized treatments based on specific patient profiles. Exosome-based diagnostics and therapies complement personalized medicine techniques, giving precise and patient-specific answers.

Key Trends:

Increasing Investment and Research Funding:

Exosome-based diagnostics and therapies research is seeing considerable investment and funding increases. Governments, research organizations, and commercial enterprises are increasingly recognizing the value of exosomes in early disease detection and tailored therapy resulting in rising funding.

Advances in Exosome Isolation and Purification Techniques

: The industry is being driven ahead by technological developments in exosome isolation and purification technologies. Improved techniques such as ultracentrifugation, microfluidics and immunocapture approaches increase the efficiency and yield of exosome extraction, making it easier to develop dependable diagnostic and therapeutic applications.

Growing Applications in Oncology:

The use of exosomes in cancer diagnosis and treatment is a growing trend. Exosomes serve an important function in cell-to-cell communication and can transport biomarkers for many cancers. They are being explored for their potential to deliver anti-cancer drugs directly to tumor cells, minimizing side effects and improving treatment efficacy.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Exosome Diagnostic and Therapeutic Market Regional Analysis

Here is a more detailed regional analysis of the global exosome diagnostic and therapeutic market:

North America

According to Verified Market Research, North America is expected to dominate the global exosome diagnostic and therapeutic market.

North America, particularly the United States is dominating. This leadership is underpinned by significant investments in biotechnology research, superior healthcare infrastructure and a favorable regulatory environment.

The United States, as a biotech innovation and commercialization hub, benefits from broad collaborations across academia, business and government organizations.

These characteristics contribute to significant advances in exosome-based diagnostics and therapies, putting North America at the forefront of market growth and adoption.

The region's significant emphasis on precision medicine strengthens its leadership position in using exosomes for therapeutic applications.

Asia Pacific

According to Verified Market Research, Asia Pacific is fastest growing region in global exosome diagnostic and therapeutic market.

Asia-Pacific (APAC) is the fastest-growing region owing to developing healthcare infrastructure, rising research spending and an increasing prevalence of chronic diseases.

Countries such as China, Japan and South Korea are critical to this rise, which is fueled by government programs supporting biotechnology and tailored treatment.

The region benefits from an increasing emphasis on precision healthcare and the implementation of new technologies. With a growing market for diagnostics and therapies, APAC offers considerable prospects for exosome-based inventions, making it a vital focus for both scientific improvements and commercial expansion in the biotechnology sector.

Global Exosome Diagnostic and Therapeutic Market: Segmentation Analysis

The Global Exosome Diagnostic and Therapeutic Market is segmented based on Source, Technology, Application and Geography.

Global Exosome Diagnostic and Therapeutic Market, By Source

• Autologous Exosomes
• Allogeneic Exosomes

Based on Source, the Global Exosome Diagnostic and Therapeutic Market is separated into Autologous Exosomes and Allogeneic Exosomes. Autologous exosomes, which are produced from a patient's own cells, dominate the global exosome diagnostic and therapeutic market due to their decreased risk of immunological rejection and adverse effects. These exosomes are becoming increasingly popular for personalized medicine and therapeutic applications, as they provide individualized treatments that are precisely aligned with the patient's specific biological makeup, improving clinical safety and efficacy.

Global Exosome Diagnostic and Therapeutic Market, By Technology

• Electron Microscopy
• Flow Cytometry
• Mass Spectrometry
• Nanoparticle Tracking Analysis (NTA)

Based on Technology, Global Exosome Diagnostic and Therapeutic Market is divided into Electron Microscopy, Flow Cytometry, Mass Spectrometry, Nanoparticle Tracking Analysis (NTA). In the Global Exosome Diagnostic and Therapeutic Market, Flow Cytometry is the dominant technique. Its dominance is due to its great sensitivity, ability to examine numerous parameters concurrently and adaptability for high-throughput study. Flow cytometry allows for exact exosome characterization and quantification, making it indispensable in research and clinical contexts. This technology's extensive use emphasizes its importance in developing exosome diagnostics and therapies.

Global Exosome Diagnostic and Therapeutic Market, By End-User

• Hospitals and Clinics
• Research and Academic Institutes
• Biotechnology and Pharmaceutical Companies

Based on End-User, Global Exosome Diagnostic and Therapeutic Market is divided into Hospitals and Clinics, Research and Academic Institutes, Biotechnology and Pharmaceutical Companies Biotechnology and pharmaceutical market dominate the global exosome diagnostic and therapeutic market. This supremacy stems from enormous investments in R&D, extensive clinical studies and increasing technological capabilities. These firms are at the forefront of transforming exosome research into useful diagnostic tools and medicinal applications, hence driving market growth and innovation. Their leadership is critical in introducing exosome-based solutions into the healthcare sector.

Global Exosome Diagnostic and Therapeutic Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the Geography, the Global Exosome Diagnostic and Therapeutic Market divided into North America, Europe, Asia Pacific and Rest of the World. North America dominates the global exosome diagnostic and therapeutic market, owing to considerable investments in biotechnology, modern healthcare infrastructure and supporting regulatory frameworks. Asia-Pacific (APAC) is the fastest-growing area, with China, Japan and South Korea leading the way because to expanded healthcare infrastructure, greater research spending, and a growing emphasis on personalized medicine and biotechnology developments.

Key Players

• The Global Exosome Diagnostic and Therapeutic Market study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Thermo Fisher Scientific, Inc., Lonza Group AG, Bio-Techne Corp, Miltenyi Biotec GmbH, Malvern Instruments, Inc., BioVision, Inc., System Biosciences LLC, Evox Therapeutics Ltd, ExCoBio, Inc., BioCat GmbH, NanoSomix, Inc., Exosome Diagnostics, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Global Exosome Diagnostic and Therapeutic Market Recent Developments
• In September 2023, INOVIQ and ResearchDx signed a license and supply deal for their EXO-NET exosome capture technology. Through this partnership, ResearchDx added EXO-NET technology into its portfolio exosome diagnostic services.
• In April 2022, INOVIQ and the University of Queensland (UQ) increased their relationship to develop exosome-based ovarian cancer screening tools. INOVIQ has the exclusive rights to license and commercialize an exosome-based early detection test for ovarian cancer.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Exosome Diagnostic And Therapeutic Market, By Source

• Autologous Exosomes
• Allogeneic Exosomes

5. Exosome Diagnostic And Therapeutic Market, By Technology

• Electron Microscopy
• Flow Cytometry
• Mass Spectrometry
• Nanoparticle Tracking Analysis (NTA)

6. Exosome Diagnostic And Therapeutic Market, By End-User

• Hospitals and Clinics
• Research and Academic Institutes
• Biotechnology and Pharmaceutical Companies

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Thermo Fisher Scientific Inc
• Lonza Group AG
• Bio-Techne Corp
• Miltenyi Biotec GmBH
• Malvern Instruments Inc
• BioVision Inc
• System Biosciences LLC
• Evox Therapeutics Ltd
• ExCoBio Inc
• BioCat GmbH
• NanoSomix Inc
• Exosome Diagnostics Inc

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References